Molecularly defined renal cell carcinomas include TFE3-rearranged renal cell carcinoma (TFE3-RCC) and TFEB-altered renal cell carcinoma (TFEB-RCC). There is significant morphologic and immunophenotypic overlap between these entities and common renal tumors, such that molecular testing is often required to make the diagnosis.
Herein, we reviewed our reference laboratory experience pertaining to TFE3 and TFEB FISH testing, targeted next generation RNA sequencing (NGS), and GPNMB immunohistochemistry (IHC). Most FISH testing (2963/3543, 83.6%) was performed on renal tumors. TFE3 FISH showed rearrangements in 449 of 2467 specimens (18.2%), including 281 (of 1887, 14.9%) renal tumors. TFEB FISH identified an abnormality in 107 of 1076 (9.9%) renal tumors, including 52 (of 107, 48.6%) rearrangements, 41 (of 107, 38.3%) amplifications, or 14 (of 107, 13.1%) with both rearrangements and amplifications. More specifically, TFE3-rearranged, TFEB-rearranged, TFEB-amplified, and TFEB-rearranged/amplified renal tumors occurred in females in 54%, 69.6%, 39.1%, and 40% of cases, respectively. The pediatric and young adult population (aged ≤21) included 44 (of 121, 36.3%) TFE3-RCC and 9 (of 50, 18%) TFEB-RCC. TFE3-RCC fusion partners included RBM10, NONO, ASPSCR1, FUBP1, SFPQ, MAPK1IP1L, and PRCC. TFEB-rearranged RCC fusion partners SYNRG and BYSL were identified. Diffuse GPNMB expression was seen in 92% of TFE3-RCC (24/26; median H-score 275), 100% of TFEB-rearranged RCC (19/19; median H-score 300), and 100% of TFEB-amplified RCC (17/17; 240). Finally, our cohort included 5 eosinophilic TFEB-amplified RCCs with non-focal keratin 20 expression. This large series of TFE3-RCC and TFEB-RCC provides population data regarding these rare tumors and demonstrates the clinical value of targeted FISH strategies. Our results suggest that GPNMB IHC is an effective screen for TFE3-RCC and TFEB-RCC. Additionally, we report a RCC harboring a novel SYNRG::TFEB fusion.
Human pathology. 2025 May 15 [Epub ahead of print]
Rumeal D Whaley, Daniel R Sill, Burak Tekin, Micheal R McCarthy, John C Cheville, Kingsley Ebare, Melissa L Stanton, Jordan P Reynolds, Aditya Raghunathan, Loren P Herrera Hernandez, Rafael E Jimenez, Vidit Sharma, Stephen A Boorjian, Bradley C Leibovich, Christopher D Hofich, Saba Alvand, Ganesh P Pujari, Benjamin R Kipp, Rhett P Ketterling, Katherine B Geiersbach, Patricia T Greipp, William R Sukov, Kevin C Halling, Sounak Gupta
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., The Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, USA. Electronic address: ., The Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., The Department of Urology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., The Department of Urology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., The Department of Urology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: ., Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: .
PubMed http://www.ncbi.nlm.nih.gov/pubmed/40381702